Maxim Group Maintains Buy on Cryo-Cell International, Lowers Price Target to $8.5
Morgan Stanley Maintains Equal-Weight on Magna International, Lowers Price Target to $40
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
Biohaven Says Data From Phase 1 Of BHV-1300 Shows Rapid And Deep Reductions In Total IgG, For The Potential Treatment Of Autoimmune Disease
Reported Saturday, Amgen And AstraZeneca TEZSPIRE Phase III Trial Confirms Rapid And Lasting Relief In Nasal Polyps, Cutting Surgery Risk By 98%
Earnings Call Summary | Acme United(ACU.US) Q4 2024 Earnings Conference